Tang C, Mo X, Niu Q, Wahafu A, Yang X, Qui M
Cell Chem Biol. 2020; 28(5):636-647.e5.
PMID: 33326750
PMC: 10053325.
DOI: 10.1016/j.chembiol.2020.11.010.
Alsaleh N, Persaud I, Brown J
PLoS One. 2016; 11(12):e0167366.
PMID: 27907088
PMC: 5131952.
DOI: 10.1371/journal.pone.0167366.
Mayati A, Bruyere A, Moreau A, Jouan E, Denizot C, Parmentier Y
PLoS One. 2015; 10(12):e0144667.
PMID: 26657401
PMC: 4675551.
DOI: 10.1371/journal.pone.0144667.
Wemhoner K, Kanyshkova T, Silbernagel N, Fernandez-Orth J, Bittner S, Kiper A
Front Mol Neurosci. 2015; 8:63.
PMID: 26578877
PMC: 4630678.
DOI: 10.3389/fnmol.2015.00063.
Wender P, Axtman A, Golden J, Kee J, Sirois L, Quiroz R
Org Chem Front. 2015; 1(10):1166-1171.
PMID: 25632347
PMC: 4304288.
DOI: 10.1039/c4qo00228h.
Systems Biology Strategy Reveals PKCδ is Key for Sensitizing TRAIL-Resistant Human Fibrosarcoma.
Hayashi K, Tabata S, Piras V, Tomita M, Selvarajoo K
Front Immunol. 2015; 5:659.
PMID: 25601862
PMC: 4283611.
DOI: 10.3389/fimmu.2014.00659.
Sirtuin inhibitors as anticancer agents.
Hu J, Jing H, Lin H
Future Med Chem. 2014; 6(8):945-66.
PMID: 24962284
PMC: 4384657.
DOI: 10.4155/fmc.14.44.
Modulation of transglutaminase 2 activity in H9c2 cells by PKC and PKA signalling: a role for transglutaminase 2 in cytoprotection.
Almami I, Dickenson J, Hargreaves A, Bonner P
Br J Pharmacol. 2014; 171(16):3946-60.
PMID: 24821315
PMC: 4128055.
DOI: 10.1111/bph.12756.
Munc18-1 redistributes in nerve terminals in an activity- and PKC-dependent manner.
Cijsouw T, Weber J, Broeke J, Broek J, Schut D, Kroon T
J Cell Biol. 2014; 204(5):759-75.
PMID: 24590174
PMC: 3941046.
DOI: 10.1083/jcb.201308026.
Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis.
Luu W, Zerenturk E, Kristiana I, Bucknall M, Sharpe L, Brown A
J Lipid Res. 2013; 55(3):410-20.
PMID: 24363437
PMC: 3934726.
DOI: 10.1194/jlr.M043257.
Roles of PKC and phospho-adducin in transepithelial fluid secretion by Malpighian tubules of the yellow fever mosquito.
Miyauchi J, Piermarini P, Yang J, Gilligan D, Beyenbach K
Tissue Barriers. 2013; 1(1).
PMID: 24062972
PMC: 3779481.
DOI: 10.4161/tisb.23120.
Structure prediction and validation of the ERK8 kinase domain.
Strambi A, Mori M, Rossi M, Colecchia D, Manetti F, Carlomagno F
PLoS One. 2013; 8(1):e52011.
PMID: 23326322
PMC: 3543423.
DOI: 10.1371/journal.pone.0052011.
Testing the promiscuity of commercial kinase inhibitors against the AGC kinase group using a split-luciferase screen.
Jester B, Gaj A, Shomin C, Cox K, Ghosh I
J Med Chem. 2012; 55(4):1526-37.
PMID: 22257127
PMC: 3328412.
DOI: 10.1021/jm201265f.
A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells.
Visnyei K, Onodera H, Damoiseaux R, Saigusa K, Petrosyan S, de Vries D
Mol Cancer Ther. 2011; 10(10):1818-28.
PMID: 21859839
PMC: 3191241.
DOI: 10.1158/1535-7163.MCT-11-0268.
Inhibition of glucose-stimulated insulin secretion by Ro 31-8220, a protein kinase C inhibitor.
Persaud S, Jones P
Endocrine. 2010; 3(4):285-9.
PMID: 21153176
DOI: 10.1007/BF03021407.
Targeting CREB for cancer therapy: friend or foe.
Xiao X, Li B, Mitton B, Ikeda A, Sakamoto K
Curr Cancer Drug Targets. 2010; 10(4):384-91.
PMID: 20370681
PMC: 4206256.
DOI: 10.2174/156800910791208535.
Poster communications.
Br J Pharmacol. 2008; 109(Suppl):67P-142P.
PMID: 19108269
PMC: 2175552.
Possible bi-directional link between ET(A) receptors and protein kinase C in rat blood vessels.
Northover A, Northover B
Mediators Inflamm. 1995; 4(1):55-9.
PMID: 18475617
PMC: 2365604.
DOI: 10.1155/S096293519500010X.
Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to alpha-adrenoceptor stimulation.
Mueed I, Zhang L, MacLeod K
Br J Pharmacol. 2005; 146(7):972-82.
PMID: 16205724
PMC: 1751237.
DOI: 10.1038/sj.bjp.0706398.
Effects of bisindolylmaleimide PKC inhibitors on p90RSK activity in vitro and in adult ventricular myocytes.
Roberts N, Haworth R, Avkiran M
Br J Pharmacol. 2005; 145(4):477-89.
PMID: 15821757
PMC: 1576162.
DOI: 10.1038/sj.bjp.0706210.